HOUSE_OVERSIGHT_013893.jpg

2.69 MB

Extraction Summary

3
People
5
Organizations
3
Locations
0
Events
2
Relationships
5
Quotes

Document Information

Type: Publication excerpt / evidence document
File Size: 2.69 MB
Summary

This document is a page from a business book (likely 'The 4-Hour Workweek' by Tim Ferriss, based on the mention of BrainQUICKEN) included in a House Oversight document production. It outlines business strategies regarding product testing, pricing, and distribution exclusivity. The text contrasts a failed entrepreneur named Sarah with Ed Byrd ('Mr. Creatine'), explaining how Byrd succeeded with his product NO2 by securing exclusive distribution with GNC and maintaining high price points.

People (3)

Name Role Context
Sarah Entrepreneur (hypothetical or case study)
Used as an example of failed retail planning regarding t-shirt sales.
Ed Byrd Entrepreneur / Founder of MRI
Referred to as 'Mr. Creatine'. Used as a successful case study for product distribution and positioning.
Narrator Author/Business Owner
First-person narrator ('I had one single supplement...') who owned BrainQUICKEN. Context suggests this is likely Tim ...

Organizations (5)

Name Type Context
MRI
San Francisco-based company owned by Ed Byrd.
GNC
Retail chain given exclusive rights to sell NO2.
BrainQUICKEN
Supplement company owned by the narrator (also sold as BodyQUICK).
eBay
Mentioned as a platform for 'rogue discounters'.
House Oversight Committee
Implied by the bates stamp 'HOUSE_OVERSIGHT_013893'.

Locations (3)

Location Context
Base of Ed Byrd's company, MRI.
Where Ed Byrd drives his Lamborghini.
Market where NO2 was a top-seller.

Relationships (2)

Ed Byrd Owner/Founder MRI
His San Francisco–based company, MRI...
Ed Byrd Business Partner GNC
NO2 was... sold exclusively through GNC stores nationwide.

Key Quotes (5)

"ED 'MR. CREATINE' BYRD is no Sarah. He does not invest and hope for the best."
Source
HOUSE_OVERSIGHT_013893.jpg
Quote #1
"First, the more competing resellers there are, the faster your product goes extinct."
Source
HOUSE_OVERSIGHT_013893.jpg
Quote #2
"The product is dead and you need to create a new product."
Source
HOUSE_OVERSIGHT_013893.jpg
Quote #3
"Otherwise, rogue discounters on eBay and mom-and-pop independents will drive you broke."
Source
HOUSE_OVERSIGHT_013893.jpg
Quote #4
"Ed drives a Lamborghini down the California coast when not traveling or in the office with his small focused staff and his two Australian shepherds."
Source
HOUSE_OVERSIGHT_013893.jpg
Quote #5

Full Extracted Text

Complete text extracted from the document (3,487 characters)

To make matters worse, the four local stores have already started discounting her shirts to compete among one another and are killing their own profit margins. Two weeks later, reorders disappear. Sarah abandons retail and returns to her website demoralized. Sales online have dropped to almost nothing with new competition. She has not recouped her initial investment, and she still has 50 shirts in her garage.
Not good.
It all could have been prevented with proper testing and planning.
ED “MR. CREATINE” BYRD is no Sarah. He does not invest and hope for the best.
His San Francisco–based company, MRI, had the top-selling sports supplement in the U.S. from 2002–2005, NO2. It is still a top-seller despite dozens of imitators. He did it through smart testing, smart positioning, and brilliant distribution.
Prior to manufacturing, MRI first offered a low-priced book related to the product through ¼-page advertisements in men’s health magazines. Once the need had been confirmed with a mountain of book orders, NO2 was priced at an outrageous $79.95, positioned as the premium product on the market, and sold exclusively through GNC stores nationwide. No one else was permitted to sell it.
How can it make sense to turn away business? There are a few good reasons.
First, the more competing resellers there are, the faster your product goes extinct. This was one of Sarah’s mistakes.
It works like this: Reseller A sells the product for your recommended advertised price of $50, then reseller B sells it for $45 to compete with A, and then C sells it for $40 to compete with A and B. In no time at all, no one is making profit from selling your product and reorders disappear. Customers are now accustomed to the lower pricing and the process is irreversible. The product is dead and you need to create a new product. This is precisely the reason why so many companies need to create new product after new product month after month. It’s a headache.
I had one single supplement, BrainQUICKEN® (also sold as BodyQUICK®) for six years and maintained a consistent profit margin by limiting wholesale distribution, particularly online, to the top one or two largest resellers who could move serious quantities of product and who agreed to maintain a minimum advertised pricing.24 Otherwise, rogue discounters on eBay and mom-and-pop independents will drive you broke.
Second, if you offer someone exclusivity, which most manufacturers try to avoid, it can work in your favor. Since you are offering one company 100% of the distribution, it is possible to negotiate better profit margins (offering less of a discount off of retail price), better marketing support in-store, faster payment, and other preferential treatment.
It is critical that you decide how you will sell and distribute your product before you commit to a product in the first place. The more middlemen are involved, the higher your margins must be to maintain profitability for all the links in the chain.
Ed Byrd realized this and exemplifies how doing the opposite of what most do can reduce risk and increase profit. Choosing distribution before product is just one example.
Ed drives a Lamborghini down the California coast when not traveling or in the office with his small focused staff and his two Australian shepherds. This outcome is not accidental. His product-creation methods—and those of the New Rich in general—can be emulated.
Here’s how you do it in the fewest number of steps.
HOUSE_OVERSIGHT_013893

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document